Publisher
Springer Berlin Heidelberg
Reference60 articles.
1. Adams S, Baum RP, Stuckensen T, et al. (1998) Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255–1260
2. Ang KK, Berkey BA, Tu X, et al. (2002) Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62:7350–7356
3. Barker JL Jr,Garden AS,Ang KK,,et al.(2004) Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 59:960–970
4. Benchaou M, Lehmann W, Slosman DO, et al. (1996) The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol 116:332–335
5. Brink I, Kleznr T, Krause T, et al. (2002) Lymph node staging in extracranial head and neck cancer with FDG PET-appropriate uptake period and size-dependence of the results. Nuklearmedizin 41:108–113